Evaluation of a tetrazolium salt test to determine absence of live mycobacteria in tuberculin purified protein derivative

被引:3
作者
Bedwell, J [1 ]
Kairo, SK [1 ]
Corbel, MJ [1 ]
机构
[1] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England
关键词
D O I
10.1006/biol.2001.0267
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Current methodology to determine absence of live mycobacteria in tuberculin purified protein derivative (PPD) takes up to 8 weeks to perform and may also involve testing on animals. In this paper we describe an in vitro test utilising the tetrazolium salt, 2,3-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT) to monitor the absence of live Mycobacterium tuberculosis (Mtb) in PPD. In the presence of live cells XTT is converted to a coloured formazan product that can be measured spectrophotometrically. Live mycobacteria present in spiked PPD were detected by a marked change in optical density above background levels. This; test is easy to perform and is complete in just 48 hr.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 17 条
[1]  
Abate G, 1998, INT J TUBERC LUNG D, V2, P1011
[2]  
[Anonymous], 1983, J IMMUNOL METH
[3]   Reduction of a tetrazolium salt, CTC, by intact HepG2 human hepatoma cells: subcellular localisation of reducing systems [J].
Bernas, T ;
Dobrucki, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1451 (01) :73-81
[4]  
*EUR PHARM COMM, 1999, EUR PHARM, P1289
[5]  
FLORES RG, 1995, J CLIN MICROBIOL, V33, P1842
[6]   Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines [J].
Kairo, SK ;
Bedwell, J ;
Tyler, PC ;
Carter, A ;
Corbel, MJ .
VACCINE, 1999, 17 (19) :2423-2428
[7]  
Long ER, 1931, ARCH PATHOL, V12, P956
[8]  
MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69
[10]   A SIMPLIFIED NEW ASSAY FOR ASSESSMENT OF FUNGAL CELL-DAMAGE WITH THE TETRAZOLIUM DYE, (2,3)-BIS-(2-METHOXY-4-NITRO-5-SULFENYL)-(2H)-TETRAZOLIUM-5-CARBOXANILIDE (XTT) [J].
MESHULAM, T ;
LEVITZ, SM ;
CHRISTIN, L ;
DIAMOND, RD .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) :1153-1156